about
Hydradenitis suppurativa and inflammatory bowel disease: An unusual, but existing associationEscherichia coli Nissle 1917 in Ulcerative Colitis Treatment: Systematic Review and Meta-analysisSeronegative Celiac Disease and Immunoglobulin Deficiency: Where to Look in the Submerged Iceberg?Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015Furazolidone-based therapies for Helicobacter pylori infection: a pooled-data analysisReflux symptoms in professional opera choristers.Argon plasma coagulation of hemorrhagic solitary rectal ulcer syndrome.Mycophenolate mofetil in the treatment of autoimmune HCV-associated haematological disorders showing steroid resistance or dependence.Symptom patterns can distinguish diverticular disease from irritable bowel syndrome.Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: a pooled data analysis.Anisakis pegreffi etiological agent of gastric infections in two Italian women.Ulcerative colitis: from inflammation to cancer. Do estrogen receptors have a role?Liver fibrosis in primary intestinal lymphangiectasia: An undervalued topicEvolution of nonspecific duodenal lymphocytosis over 2 years of follow-up.Lactobacillus reuteri therapy to reduce side-effects during anti-Helicobacter pylori treatment in children: a randomized placebo controlled trial.Small intestinal bacterial overgrowth and celiac disease: A systematic review with pooled-data analysis.Mucosal molecular pattern of tissue transglutaminase and interferon gamma in suspected seronegative celiac disease at marsh 1 and 0 stagesEpithelial turnover in duodenal familial adenomatous polyposis: A possible role for estrogen receptors?Tumor necrosis factor alpha in ulcerative colitis and diverticular disease associated colitis.Phytoestrogens/insoluble fibers and colonic estrogen receptor β: randomized, double-blind, placebo-controlled study.How antibiotic resistances could change Helicobacter pylori treatment: A matter of geography?Segmental colitis associated with diverticula: a rare clinical entity and a new challenge for the gastroenterologist.Effects of Helicobacter pylori eradication on early stage gastric mucosa-associated lymphoid tissue lymphoma.Dietary lifestyle and colorectal cancer onset, recurrence, and survival: myth or reality?Inflammatory bowel disease, liver diseases and endothelial function: is there a linkage?Sequential vs. prolonged 14-day triple therapy for Helicobacter pylori eradication: the meta-analysis may be influenced by 'geographical weighting'.The association between cardiac and gastrointestinal disorders: causal or casual link?Stool Investigations for Colorectal Cancer Screening: From Occult Blood Test to DNA Analysis.Gastrointestinal bleeding from vascular malformations: Is octreotide effective to rescue difficult-to-treat patients?The Interaction Between Celiac Disease and Intestinal Microbiota.Lymphocytic duodenitis or microscopic enteritis and gluten-related conditions: what needs to be explored?Comment on "Helicobacter pylori Outer Membrane Protein 18 (Hp1125) Is Involved in Persistent Colonization by Evading Interferon- γ Signaling".HISTAMINE AND HISTAMINERGIC RECEPTORS IN COLORECTAL CANCER: FROM BASIC SCIENCE TO EVIDENCE-BASED MEDICINE.Acute pancreatitis in elderly patients: A retrospective evaluation at hospital admission.Role of concomitant therapy for Helicobacter pylori eradication: A technical note.Helicobacter pylori DNA isolation in the stool: an essential pre-requisite for bacterial noninvasive molecular analysis.Does infliximab short infusion have a beneficial impact on the quality of life in patients with inflammatory bowel diseases? A single centre prospective evaluation.May the assessment of baseline mucosal molecular pattern predict the development of gluten related disorders among microscopic enteritis?Macronutrient intakes in obese subjects with or without small intestinal bacterial overgrowth: an alimentary survey.Noninvasive molecular analysis of Helicobacter pylori: Is it time for tailored first-line therapy?
P50
Q26745455-9406251A-C9D3-4ECC-BBE4-18B643FA10B6Q26772182-2CB073F9-7CD5-40B7-8712-AFDF234BB619Q26786935-D3DCC216-EC12-40C9-BB2D-963818C26CB0Q26801010-DA7461FE-090C-4B77-834C-1E372EA674BDQ26823010-393BCF8D-C831-4A23-8BF5-9414ADBC6DD3Q30542438-DFF61C35-E5EB-423E-8BAE-3AEB3CCF3765Q31013190-83779AF3-AAD8-48C7-9302-385ED1D27021Q33349902-45CA7F99-5F20-45F5-8E2F-E6818163D620Q33459058-0DA5345A-FF6A-4C9B-AB64-02E62DF4EED3Q33468849-A12A84D4-BA18-4894-AEE4-40C71045DDCEQ33488680-C4D923E2-F8EC-4665-978F-2F84AA24D4EFQ34137246-4D6E0ED6-9845-4465-AC43-8DA54345BC5AQ34263377-93008DF0-CFC2-43C8-B514-07AAAF07A904Q34483440-A895F8F9-EC3E-41DF-8254-19B8DB01A1A0Q34572969-2F8414E2-869A-46ED-AE17-D83F76E459DBQ36278242-08A5BF75-15BA-44F3-AC29-8146B5B5C20FQ36449613-6AC7369E-22FE-4CBB-A27C-59C398401194Q36682613-B3F5C2B5-7D72-4B15-BBB5-CE220CE49963Q36952397-D2BA6B16-092E-4E39-8E70-8371504C8D06Q37034028-0BC52B1B-3051-4CEB-B818-A325975923DDQ37378899-E69A986F-BBB9-4B01-BCEA-63F5CC09D1E6Q37504239-350BEA30-9EDD-4A3B-8034-009F5D6B9C53Q37561833-DE83382E-71D7-4BBD-AB6F-175074305CA2Q38033464-912D784D-6896-4003-B6D9-CAB0FA51296DQ38271693-EA7372AC-DDDD-42AA-8B89-06C1DE313D0DQ38542168-48D77766-C610-43A5-A9E5-23CA49996563Q38678820-6E934D1E-9C92-4BD1-A676-5A3D2A799708Q38753052-9D1DF568-0EF2-4F11-8DAA-977B88B9958FQ38946528-7583FEC4-A655-4AF7-9ABB-5C88FDE89D30Q38980629-C3070804-01E2-402A-BC58-4C26D21D7463Q39401436-1DA66F93-604C-414F-8B29-3C6AC92705C1Q39770220-97CC30B7-053C-4BA2-8C69-876BFA239877Q39904103-E2348CD3-30A1-4921-979E-F1157A73A708Q40066442-646525A5-3B02-4EC4-A05D-D479575DDEC2Q40482860-8EA53742-DC48-432C-9DED-D8BF6654BFA5Q40521935-D0B2F732-D360-400E-B31F-BF88C74780FBQ40794452-02514BF7-CD61-4BAC-A06F-B4E2FCC0534FQ41128408-80C115E7-0FCB-4502-9591-F6731D0D64EEQ41352732-2FE9DBA8-39AC-4679-9665-3D2ACA8C9AD1Q42362197-8509F2A4-29B9-418B-98E4-79798D1BE0CC
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Enzo Ierardi
@ast
Enzo Ierardi
@en
Enzo Ierardi
@es
Enzo Ierardi
@nl
Enzo Ierardi
@sl
type
label
Enzo Ierardi
@ast
Enzo Ierardi
@en
Enzo Ierardi
@es
Enzo Ierardi
@nl
Enzo Ierardi
@sl
prefLabel
Enzo Ierardi
@ast
Enzo Ierardi
@en
Enzo Ierardi
@es
Enzo Ierardi
@nl
Enzo Ierardi
@sl
P106
P1153
26643538200
56962759800
P21
P31
P496
0000-0001-7275-5080